[LXRX] YoY Quarter Result on 30-Sep-2014 [#Q3]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
06-Nov-2014
Financial Year
2014
Quarter
30-Sep-2014 [#Q3]
Profit Trend
QoQ- -55.59%
YoY- -27.92%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Revenue 26,942 27,717 566 419 238 372 355 105.62%
PBT -30,722 -36,015 -35,282 -40,498 -31,658 -29,539 -26,103 2.75%
Tax 2,034 1,135 1,627 205 503 -576 560 23.95%
NP -30,722 -36,015 -35,282 -40,498 -31,658 -29,539 -26,103 2.75%
Tax Rate - - - - - - - -
Total Cost 57,664 63,732 35,848 40,917 31,896 29,911 26,458 13.85%
Ratio Analysis
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
NP Margin -114.03 -129.94 -6,233.57 -9,665.39 -13,301.68 -7,940.59 -7,352.96 -50.03%
Per Share
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
EPS -0.29 -0.35 -0.34 -0.55 -0.43 -0.42 -0.54 -9.83%
EPS Diluted -0.29 -0.35 -0.34 -0.55 -0.43 -0.42 -0.54 -9.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.